CDC advisory panel delays decision on Johnson & Johnson Covid-19 vaccine
The U.S. government’s recommended pause on use of the Johnson & Johnson Covid-19 vaccine is unlikely to be lifted for at least another week or 10 days, after a committee of independent experts declined Wednesday to vote on whether use of the vaccine should resume.
The Food and Drug Administration and the Centers for Disease Prevention and Control urged states to stop using the J&J vaccine on Tuesday to seek advice from the expert panel on some rare but serious clotting problems seen in a small number of people who received the vaccine. Six cases have been identified — and J&J officials indicated a possible seventh is being investigated. One person has died.
Read Original Article: CDC advisory panel delays decision on Johnson & Johnson Covid-19 vaccine »
